Passage Bio (NYSE:GFL) Now Covered by Jefferies Financial Group

Research analysts at Jefferies Financial Group initiated coverage on shares of Passage Bio (NYSE:GFL) in a report released on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $26.00 price target on the stock. Jefferies Financial Group’s target price suggests a potential upside of 37.20% from the stock’s previous close.

Several other research analysts have also recently commented on the stock. CIBC upped their target price on shares of Passage Bio from $28.00 to $29.50 and gave the stock a “neutral” rating in a research report on Friday, June 26th. Stifel Nicolaus initiated coverage on shares of Passage Bio in a research report on Monday, March 30th. They issued a “buy” rating and a $26.00 target price for the company. Zacks Investment Research cut shares of Passage Bio from a “buy” rating to a “hold” rating in a research report on Monday, June 15th. Scotiabank initiated coverage on shares of Passage Bio in a research report on Monday, March 30th. They issued an “outperform” rating and a $23.00 target price for the company. Finally, Royal Bank of Canada upped their target price on shares of Passage Bio from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Thursday, June 25th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $23.32.

GFL opened at $18.95 on Wednesday. Passage Bio has a fifty-two week low of $11.92 and a fifty-two week high of $20.97. The stock’s 50-day simple moving average is $18.45.

Passage Bio (NYSE:GFL) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.35) by $0.33. The business had revenue of $694.42 million for the quarter, compared to analyst estimates of $632.34 million. Analysts expect that Passage Bio will post -0.24 EPS for the current year.

Passage Bio Company Profile

GFL Environmental Inc operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers.

See Also: How to Invest in the Dividend Aristocrat Index

Analyst Recommendations for Passage Bio (NYSE:GFL)

Receive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.